Skip to main content
Clinical Trials/NCT04039594
NCT04039594
Recruiting
Not Applicable

Outcomes of Patients With Venoarterial Extracorporeal Membrane Oxygenation

Beijing Anzhen Hospital1 site in 1 country500 target enrollmentAugust 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiogenic Shock
Sponsor
Beijing Anzhen Hospital
Enrollment
500
Locations
1
Primary Endpoint
All-cause mortality
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

Venoarterial extracorporeal membrane oxygenation (VA ECMO)-also referred to as extracorporeal life support-is a form of temporary mechanical circulatory support and simultaneous extracorporeal gas exchange. The objective of this observational, cohort study is to evaluate the short-term and long-term outcomes of patients with VA ECMO.

Registry
clinicaltrials.gov
Start Date
August 1, 2019
End Date
July 31, 2025
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Beijing Anzhen Hospital
Responsible Party
Principal Investigator
Principal Investigator

Xiaotong Hou

Chief, Center for Cardiac Intensive Care

Beijing Anzhen Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients receiving VA ECMO for cardiopulmonary support

Exclusion Criteria

  • Refusal of consent

Outcomes

Primary Outcomes

All-cause mortality

Time Frame: 30 days

Secondary Outcomes

  • ECMO-related complications(30 days)
  • Other complications(30 days)
  • All-cause mortality(365 days)
  • Rate of successful weaning from ECMO(30 days)
  • Duration stay at ICU and hospital(365 days)

Study Sites (1)

Loading locations...

Similar Trials